Merck KGaA — ERA-LEARN

Skip to content
Skip to footer

Service Navigation

Home
About
Contact
newsalert

Main Menu Search

Partnerships in a Nutshell
Explore Partnerships
Support for Partnerships
Documents
News and Events
- News
- Events

Home
Partnerships in a Nutshell
Explore Partnerships
Support for Partnerships
Documents
News and Events
- News
- Events

Phase III clinical trials and registration of a new praziquantel orally disintegrating tablet formulation suitable for preschool-aged children with schistosomiasis

Home
Explore Partnerships
Partnerships
EDCTP2
Strategic actions supporting large-scale clinical trials 2016
Phase III clinical trials and registration of a new praziquantel orally disintegrating tablet formulation suitable for preschool-aged children with schistosomiasis
Merck KGaA

Full name	Merck KGaA
Short name	MERK
Type of organisation	Private non-profit research organisation
Partner Role	Partner
Country	Germany

Back to project overview

Funded by the European Union under the Grant Agreement no. 101102316. Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Union or the European Commission. Neither the European Union nor the granting authority can be held responsible for them.

Sitemap
Imprint
Privacy Policy
Submit accessibility issues
Accessibility Statement

Follow us on LinkedIn

Use of cookies

We use cookies for statistical purposes and to remember your settings. Please check our privacy and cookies policy.

Use of cookies

We use cookies for statistical purposes and to remember your settings. Please check our privacy and cookies policy.